MedPath

The Effect of Curcumin Supplementation on Recovery From Exercise-induced Muscle Damage

Not Applicable
Conditions
Exercise Induced Muscle Damage
Registration Number
NCT05346211
Lead Sponsor
St Mary's University College
Brief Summary

Recent evidence suggests that curcumin supplementation may reduce muscle inflammation, oxidative markers, and muscle damage. The most favourable dosage to elicit these ergogenic effects are yet to be established; both 750mg \& 1500mg has been shown to be effective. Curcumin supplementation has been ingested in numerous different ways however, no previous research to date has used curcumin in a hydrolysed (drinkable) format. The aim of this study is to investigate whether hydrolysed curcumin can reduce indices of muscle damage and improve recovery, whilst also examining a potential dose-response effect.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
36
Inclusion Criteria

Inclusion criteria are as follows:

  • between the age of 18-35
  • non-smoker
  • no previous history of cardiovascular, respiratory, or neurological problems
  • not taking anticoagulant medication
  • injury-free in the 3 months prior to scheduled participation in the study
Exclusion Criteria

Exclusion criteria include:

  • hypertension (<140/80)
  • any blood diseases or clotting issues,
  • injury, or previous injury in <3 months

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Blood markers72 hours post

Blood samples will be taken for analysis of markers of IL-6, IL-1β, TNF-α, IL-1, IL-4, IL-10 and CK will be taken

Ford and Fort72 hours post

Capillary sample Ford and Fort tests

Muscle Structure72 hours post

Muscle swelling - thigh girth + Ultrasound measurement

Soreness72 hours post

Pressure pain threshold

Muscle Function72 hours post

Muscular endurance

Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.